Compare INBX & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBX | VSTS |
|---|---|---|
| Founded | 2010 | 1936 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 1.0B |
| IPO Year | 2024 | 2023 |
| Metric | INBX | VSTS |
|---|---|---|
| Price | $61.49 | $7.76 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 2 | 4 |
| Target Price | N/A | ★ $5.88 |
| AVG Volume (30 Days) | 155.9K | ★ 1.3M |
| Earning Date | 03-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,300,000.00 | ★ $2,734,839,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $10.81 | $3.98 |
| 52 Week High | $94.57 | $10.04 |
| Indicator | INBX | VSTS |
|---|---|---|
| Relative Strength Index (RSI) | 37.65 | 53.19 |
| Support Level | $28.54 | $7.20 |
| Resistance Level | $85.97 | $8.18 |
| Average True Range (ATR) | 4.28 | 0.36 |
| MACD | -0.55 | 0.00 |
| Stochastic Oscillator | 21.52 | 71.01 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.